## Abstract In order to evaluate whether a sustained virologic response to therapy resumption after treatment interruption can be achieved in the setting of virologic failure, we reviewed retrospectively the data relating to 56 human immunodeficiency virus (HIV)‐infected subjects selected from 3,14
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy
✍ Scribed by Emanuela Balestrieri; Sandro Grelli; Claudia Matteucci; Antonella Minutolo; Gabriella d'Ettorre; Fiorella Di Sora; Francesco Montella; Vincenzo Vullo; Stefano Vella; Cartesio Favalli; Beatrice Macchi; Antonio Mastino
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 141 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The simultaneous expression of 19 apoptosis‐related genes was analyzed by RNA‐protection assay in peripheral blood mononuclear cells of HIV‐infected patients before and during successful antiretroviral therapy (ART). After 12 months of therapy, the expression of the pro‐apoptotic genes FAS, FAS‐L, FAF‐1, FADD, CASPASE‐8, DR3, TRAIL, TNFR‐1, TRADD, and BAX was significantly downregulated with respect to time 0, while that of BCL‐2, BCL‐XL, and MCL‐1 was significantly upregulated. The data suggest that inhibition of cell death in HIV‐positive patients under successful therapy is the result of a complex network of multifactor signaling, correlated with both death and survival of lymphocytes. J. Med. Virol. 79:111–117, 2007. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Failure to recognise infection caused by human immunodeficiency virus type 1 (HIV‐1) group O variants has been described using both serological and genetic procedures. Moreover, monitoring the response to antiretroviral therapy is a difficult task in patients infected with HIV‐1 group O
## Abstract Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as a major public health priority. As ARV resistance becomes more prevalent with extended use of existing agents, individuals with
## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with
## Abstract The aim of the study was to evaluate the mRNA expression of four relevant ABC‐transporter genes [MDR1 (P‐glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV‐positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell co
## Abstract An investigation was undertaken to determine whether specific __pol__ mutations hinder long‐term immune recovery regardless of virological response. In total, 826 patients with >50 HIV RNA copies/ml, who underwent genotypic resistance testing between 1 January 2000 and 31 December 2003